rs2745167
Variant names:
Variant summary
Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBA1
The NM_021098.3(CACNA1H):c.2603+280T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.424 in 152,150 control chromosomes in the GnomAD database, including 14,692 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.42 ( 14692 hom., cov: 34)
Consequence
CACNA1H
NM_021098.3 intron
NM_021098.3 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.196
Publications
10 publications found
Genes affected
CACNA1H (HGNC:1395): (calcium voltage-gated channel subunit alpha1 H) This gene encodes a T-type member of the alpha-1 subunit family, a protein in the voltage-dependent calcium channel complex. Calcium channels mediate the influx of calcium ions into the cell upon membrane polarization and consist of a complex of alpha-1, alpha-2/delta, beta, and gamma subunits in a 1:1:1:1 ratio. The alpha-1 subunit has 24 transmembrane segments and forms the pore through which ions pass into the cell. There are multiple isoforms of each of the proteins in the complex, either encoded by different genes or the result of alternative splicing of transcripts. Alternate transcriptional splice variants, encoding different isoforms, have been characterized for the gene described here. Studies suggest certain mutations in this gene lead to childhood absence epilepsy (CAE). [provided by RefSeq, Jul 2008]
CACNA1H Gene-Disease associations (from GenCC):
- hyperaldosteronism, familial, type IVInheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- childhood absence epilepsyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- epilepsy, childhood absence, susceptibility to, 6Inheritance: AD Classification: LIMITED Submitted by: G2P, Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -14 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.92).
BP6
Variant 16-1205545-T-C is Benign according to our data. Variant chr16-1205545-T-C is described in ClinVar as Benign. ClinVar VariationId is 1296140.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.499 is higher than 0.05.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| CACNA1H | ENST00000348261.11 | c.2603+280T>C | intron_variant | Intron 11 of 34 | 1 | NM_021098.3 | ENSP00000334198.7 | |||
| CACNA1H | ENST00000569107.6 | c.2603+280T>C | intron_variant | Intron 11 of 33 | 1 | ENSP00000454990.2 | ||||
| CACNA1H | ENST00000711493.1 | c.2603+280T>C | intron_variant | Intron 11 of 33 | ENSP00000518778.1 | |||||
| CACNA1H | ENST00000565831.7 | c.2603+280T>C | intron_variant | Intron 11 of 33 | 1 | ENSP00000455840.1 | ||||
| CACNA1H | ENST00000711450.1 | c.2603+280T>C | intron_variant | Intron 11 of 34 | ENSP00000518762.1 | |||||
| CACNA1H | ENST00000564231.6 | c.2603+280T>C | intron_variant | Intron 11 of 34 | 1 | ENSP00000457555.2 | ||||
| CACNA1H | ENST00000638323.1 | c.2564+280T>C | intron_variant | Intron 11 of 34 | 5 | ENSP00000492267.1 | ||||
| CACNA1H | ENST00000562079.6 | c.2603+280T>C | intron_variant | Intron 11 of 33 | 1 | ENSP00000454581.2 | ||||
| CACNA1H | ENST00000711438.1 | c.2564+280T>C | intron_variant | Intron 11 of 33 | ENSP00000518754.1 | |||||
| CACNA1H | ENST00000711482.1 | c.2603+280T>C | intron_variant | Intron 11 of 35 | ENSP00000518771.1 | |||||
| CACNA1H | ENST00000711485.1 | c.2603+280T>C | intron_variant | Intron 11 of 34 | ENSP00000518774.1 | |||||
| CACNA1H | ENST00000711455.1 | c.2603+280T>C | intron_variant | Intron 11 of 35 | ENSP00000518768.1 | |||||
| CACNA1H | ENST00000711483.1 | c.2603+280T>C | intron_variant | Intron 11 of 34 | ENSP00000518772.1 | |||||
| CACNA1H | ENST00000711456.1 | c.2603+280T>C | intron_variant | Intron 11 of 33 | ENSP00000518769.1 | |||||
| CACNA1H | ENST00000621827.2 | n.2603+280T>C | intron_variant | Intron 11 of 36 | 6 | ENSP00000518766.1 | ||||
| CACNA1H | ENST00000637236.3 | n.2603+280T>C | intron_variant | Intron 11 of 33 | 5 | ENSP00000492650.2 | ||||
| CACNA1H | ENST00000639478.1 | n.2603+280T>C | intron_variant | Intron 11 of 34 | 5 | ENSP00000491945.1 | ||||
| CACNA1H | ENST00000640028.1 | n.*516+280T>C | intron_variant | Intron 11 of 34 | 5 | ENSP00000491488.1 | ||||
| CACNA1H | ENST00000711442.1 | n.*2050+280T>C | intron_variant | Intron 10 of 33 | ENSP00000518758.1 | |||||
| CACNA1H | ENST00000711448.1 | n.2603+280T>C | intron_variant | Intron 11 of 35 | ENSP00000518760.1 | |||||
| CACNA1H | ENST00000711449.1 | n.2603+280T>C | intron_variant | Intron 11 of 34 | ENSP00000518761.1 | |||||
| CACNA1H | ENST00000711451.1 | n.2603+280T>C | intron_variant | Intron 11 of 35 | ENSP00000518763.1 | |||||
| CACNA1H | ENST00000711452.1 | n.2603+280T>C | intron_variant | Intron 11 of 35 | ENSP00000518764.1 | |||||
| CACNA1H | ENST00000711453.1 | n.2603+280T>C | intron_variant | Intron 11 of 35 | ENSP00000518765.1 | |||||
| CACNA1H | ENST00000711484.1 | n.2603+280T>C | intron_variant | Intron 11 of 34 | ENSP00000518773.1 | |||||
| CACNA1H | ENST00000711486.1 | n.2603+280T>C | intron_variant | Intron 11 of 36 | ENSP00000518775.1 | |||||
| CACNA1H | ENST00000711487.1 | n.2603+280T>C | intron_variant | Intron 11 of 35 | ENSP00000518776.1 | |||||
| CACNA1H | ENST00000711488.1 | n.2603+280T>C | intron_variant | Intron 11 of 34 | ENSP00000518777.1 |
Frequencies
GnomAD3 genomes AF: 0.424 AC: 64455AN: 152032Hom.: 14667 Cov.: 34 show subpopulations
GnomAD3 genomes
AF:
AC:
64455
AN:
152032
Hom.:
Cov.:
34
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.424 AC: 64520AN: 152150Hom.: 14692 Cov.: 34 AF XY: 0.419 AC XY: 31182AN XY: 74394 show subpopulations
GnomAD4 genome
AF:
AC:
64520
AN:
152150
Hom.:
Cov.:
34
AF XY:
AC XY:
31182
AN XY:
74394
show subpopulations
African (AFR)
AF:
AC:
15335
AN:
41496
American (AMR)
AF:
AC:
4908
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
AC:
1017
AN:
3470
East Asian (EAS)
AF:
AC:
362
AN:
5184
South Asian (SAS)
AF:
AC:
1691
AN:
4820
European-Finnish (FIN)
AF:
AC:
5553
AN:
10596
Middle Eastern (MID)
AF:
AC:
85
AN:
292
European-Non Finnish (NFE)
AF:
AC:
34245
AN:
67974
Other (OTH)
AF:
AC:
816
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1884
3768
5652
7536
9420
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
612
1224
1836
2448
3060
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
765
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Benign:1
Nov 22, 2019
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.